Neuronal differentiation associated with Gli3 expression predicts favorable outcome for patients with medulloblastoma

Neuropathology

Volumn 34, Issue 1, 2014, Pages 1-10

  Miyahara, Hiroaki ^a,b   Natsumeda, Manabu ^a   Yoshimura, Junichi ^a   Ogura, Ryosuke ^a   Okazaki, Kenichi ^a   Toyoshima, Yasuko ^a   Fujii, Yukihiko ^a   Takahashi, Hitoshi ^a   Kakita, Akiyoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Desmoplastic nodular; Gli3; Medulloblastoma; Neuronal differentiation; Prognosis; Sonic hedgehog

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; TRANSCRIPTION FACTOR GLI3; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER TISSUE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL ULTRASTRUCTURE; CHEMORADIOTHERAPY; CHILD; CLINICAL ARTICLE; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; GLIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDULLOBLASTOMA; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SURVIVAL PREDICTION; SURVIVAL RATE; TUMOR CELL;

DESMOPLASTIC/NODULAR; GLI3; MEDULLOBLASTOMA; NEURONAL DIFFERENTIATION; PROGNOSIS; SONIC HEDGEHOG;

CELL DIFFERENTIATION; CEREBELLAR NEOPLASMS; CHILD; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MEDULLOBLASTOMA; NERVE TISSUE PROTEINS; PROGNOSIS;

EID: 84892784106     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12052     Document Type: Article

References (44)

1. Giangaspero F, Eberhart CG, Haapasalo H, Pietsch T, Wiestler OD, Ellison DW. Medulloblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARC, 2007; 132-140.
2. Brown HG, Kepner JL, Perlman EJ etal. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study. J Neuropathol Exp Neurol 2000; 59: 857-865.
3. Eberhart CG, Kepner JL, Goldthwaite PT etal. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer 2002; 94: 552-560.
4. Giangaspero F, Rigobello L, Badiali M etal. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior. Am J Surg Pathol 1992; 16: 687-693.
5. Giangaspero F, Wellek S, Masuoka J, Gessi M, Kleihues P, Ohgaki H. Stratification of medulloblastoma on the basis of histopathological grading. Acta Neuropathol 2006; 112: 5-12.
6. Lamont JM, McManamy CS, Pearson AD, Clifford SC, Ellison DW. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 2004; 10: 5482-5493.
7. McManamy CS, Lamont JM, Taylor RE etal. Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol 2003; 62: 627-632.
8. Giangaspero F, Perilongo G, Fondelli MP etal. Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg 1999; 91: 971-977.
9. Suresh TN, Santosh V, Yasha TC etal. Medulloblastoma with extensive nodularity: a variant occurring in the very young - clinicopathological and immunohistochemical study of four cases. Childs Nerv Syst 2004; 20: 55-60.
10. Bailey CC, Gnekow A, Wellek S etal. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995; 25: 166-178.
11. Chatty EM, Earle KM. Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer 1971; 28: 977-983.
12. Ellison DW. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 2010; 120: 305-316.
13. McManamy CS, Pears J, Weston CL etal. Nodule formation and desmoplasia in medulloblastomas - defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 2007; 17: 151-164.
14. Muller W, Afra D, Schroder R, Slowik F, Wilcke O, Klug N. Medulloblastoma: survey of factors possibly influencing the prognosis. Acta Neurochir (Wien) 1982; 64: 215-224.
15. Sure U, Berghorn WJ, Bertalanffy H etal. Staging, scoring and grading of medulloblastoma. A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 1995; 132: 59-65.
16. Verma S, Tavare CJ, Gilles FH. Histologic features and prognosis in pediatric medulloblastoma. Pediatr Dev Pathol 2008; 11: 337-343.
17. Meurer RT, Martins DT, Hilbig A etal. Immunohistochemical expression of markers Ki-67, NeuN, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters. Arq Neuropsiquiatr 2008; 66: 385-390.
18. Dahmane N, Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999; 126: 3089-3100.
19. Kimura H, Stephen D, Joyner A, Curran T. Gli1 is important for medulloblastoma formation in Ptc1+/- mice. Oncogene 2005; 24: 4026-4036.
20. Shahi MH, Lorente A, Castresana JS. Hedgehog signalling in medulloblastoma, glioblastoma and neuroblastoma. Oncol Rep 2008; 19: 681-688.
21. Krauss S, Foerster J, Schneider R, Schweiger S. Protein phosphatase 2A and rapamycin regulate the nuclear localization and activity of the transcription factor GLI3. Cancer Res 2008; 68: 4658-4665.
22. Laurent JP, Chang CH, Cohen ME. A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 1985; 56: 1807-1809.
23. Tan CF, Yamada M, Toyoshima Y etal. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease. Acta Neuropathol 2009; 118: 553-560.
24. Burger PC, Grahmann FC, Bliestle A, Kleihues P. Differentiation in the medulloblastoma. A histological and immunohistochemical study. Acta Neuropathol 1987; 73: 115-123.
25. Katsetos CD, Herman MM, Frankfurter A etal. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands. Arch Pathol Lab Med 1989; 113: 1019-1029.
26. Ng D, Stavrou T, Liu L etal. Retrospective family study of childhood medulloblastoma. Am J Med Genet A 2005; 134: 399-403.
27. Pietsch T, Waha A, Koch A etal. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997; 57: 2085-2088.
28. Rudin CM, Hann CL, Laterra J etal. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009; 361: 1173-1178.
29. Alinger B, Kiesslich T, Datz C etal. Hedgehog signaling is involved in differentiation of normal colonic tissue rather than in tumor proliferation. Virchows Arch 2009; 454: 369-379.
30. ten Haaf A, Bektas N, von Serenyi S etal. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer 2009; 9: 298.
31. Fattet S, Haberler C, Legoix P etal. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics. J Pathol 2009; 218: 86-94.
32. Das P, Puri T, Suri V, Sharma MC, Sarkar C. Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome. Childs Nerv Syst 2009; 25: 825-835.
33. Shim KW, Joo SY, Kim SH, Choi JU, Kim DS. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray. J Neurosurg Pediatr 2008; 1: 196-205.
34. Packer RJ, Sutton LN, Elterman R etal. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994; 81: 690-698.
35. Gilbertson RJ, Jaros E, Perry RH, Kelly PJ, Lunec J, Pearson AD. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. Eur J Cancer 1997; 33: 609-615.
36. Miralbell R, Tolnay M, Bieri S etal. Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. J Neurooncol 1999; 45: 103-110.
37. Ohta T, Watanabe T, Katayama Y etal. TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas. Neuropathology 2006; 26: 170-177.
38. Schiffer D, Cavalla P, Migheli A etal. Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci Lett 1995; 195: 81-84.
39. Ito S, Hoshino T, Prados MD, Edwards MS. Cell kinetics of medulloblastomas. Cancer 1992; 70: 671-678.
40. Northcott PA, Korshunov A, Witt H etal. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29: 1408-1414.
41. Taylor MD, Northcott PA, Korshunov A etal. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 2012; 123: 465-472.
42. Cho YJ, Tsherniak A, Tamayo P etal. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 2011; 29: 1424-1430.
43. Schwalbe EC, Williamson D, Lindsey JC etal. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 2013; 125: 359-371.
44. Pugh GE, Coates PJ, Lane EB, Raymond Y, Quinlan RA. Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells. J Cell Sci 1997; 110 (Pt 19): 2483-2493.